To advance the pipeline for innovative therapeutics in Alzheimer’s (AD), the National Institute…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
The National Institute on Aging (NIA) has awarded a five-year grant expected to total $53.4 million to Brown…
An upcoming and free web-based documentary series explores why efforts to develop an Alzheimer’s therapy are so challenging and often end…
With the goal of warding off Alzheimer’s disease through integrative medicine, the Alzheimer’s Research and Prevention Foundation (ARPF) will…
The strain of caring for someone with Alzheimer’s disease (AD) during the hectic back-to-school season can be overwhelming. For…
To foster the cognitive stimulation of its Alzheimer’s disease (AD) residents, an Arkansas senior living center collaborated with the…
The University of California, Berkeley (UC Berkeley) will receive an expected $47 million in a federal grant that will…
Biopharmaceutical company Longeveron will use a $3 million Alzheimer’s Association grant to advance innovative research that uses adult…
To enhance care for the growing number of people with Alzheimer’s and other dementia, the U.S. Department of…
Scores of efforts to mark June’s Alzheimer’s & Brain Awareness Month are designed to raise funds and visibility around…